Brief: Moberg Pharma Unit Announces Issue Of European Patent Related To BupiZenge

Moberg Pharma AB (publ)

07/01/2021 07:05

Jan 7 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * ONCOZENGE ANNOUNCES ISSUE OF EUROPEAN PATENT RELATED TO
BUPIZENGE ® 
    * PATENT IS EXPECTED TO BE IN EFFECT UNTIL 2032.

Source text for Eikon:  ID:nWkr2vL4PG 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))